African Journal of Parasitology Research

ISSN 2756-3391

African Journal of Parasitology Research | Vol. 14, No. 9, September 2026 | pp. 808–814

DOI: 10.46882/AJPR/140808

Article Type: Research Article

Title: Detection of artemisinin-resistant Plasmodium falciparum kelch13 propeller domain mutations in patients with uncomplicated malaria

Names of Authors: Kenji Takahashi¹*, Amina Abdullahi², Lucas Moreau³

Authors’ Affiliations: ¹Institute of Tropical Medicine, Nagasaki University, Nagasaki, Japan. ²Department of Medical Microbiology, Ahmadu Bello University, Zaria, Nigeria. ³Department of Parasitology, Pasteur Institute, Paris, France.

Abstract: Plasmodium falciparum remains the primary cause of severe malaria morbidity and mortality, and the emergence of resistance to artemisinin-based combination therapies threatens global control efforts. In this study, we investigated the frequency of single nucleotide polymorphisms in the P. falciparum kelch13 (Pfk13) propeller domain among patients presenting with uncomplicated malaria. A total of 285 dried blood spot samples were collected from febrile patients confirmed positive by rapid diagnostic tests and Giemsa-stained thick blood smears. Genomic DNA was extracted and subjected to nested PCR amplification of the Pfk13 propeller region, yielding a 740 base pair fragment followed by Sanger sequencing. Out of 285 samples, successful amplification and sequencing were achieved for 264 isolates (92.6 percent). Wild-type Pfk13 sequences were observed in 241 isolates (91.3 percent), while non-synonymous mutations were detected in 23 isolates (8.7 percent). The validated resistance marker R561H was identified in 9 isolates (3.4 percent), C469Y in 6 isolates (2.3 percent), and A675V in 5 isolates (1.9 percent), alongside 3 isolates carrying synonymous mutations. Parasite clearance half-lives were prolonged (>5 hours) in 78.3 percent of patients harboring Pfk13 mutant strains compared to 6.2 percent in patients with wild-type parasites. Low-level circulation of validated Pfk13 mutations exists in the study population. Continuous molecular surveillance of antimalarial drug resistance markers is essential to guide national treatment policies and prevent widespread treatment failure.

Keywords: Plasmodium falciparum, Artemisinin resistance, Kelch13 mutations, Malaria surveillance, Sequencing

Manuscript Timeline: Received: February 14, 2026; Revised: March 28, 2026; Accepted: May 02, 2026; Published: September 07, 2026